TB Guidelines and Recommendations A to Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
- Controlling
Tuberculosis in the United States: Recommendations from the American
Thoracic Society, CDC, and Infectious Diseases Society of America. (PDF:1.11MB/84 pages)
Comprehensive discussion of practical approaches to controlling TB in the United States. Attention: Non-MDH link
- Diagnostic
Standards and Classification of TB in Adults and Children (PDF:151KB/20
pages)
Official statement of the American Thoracic Society and the Centers for Disease Control and Prevention. Attention: Non-MDH link
- Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases (2007)
An official statement from the American Thoracic Society and the Infectious Diseases Society of America. Attention: Non-MDH link
- Guidelines for Decisions Regarding TB Screening of Elementary and Secondary School Students - Minnesota Recommendations
- Guidelines
for Environmental Infection Control in Health-Care Facilities, 2003 (PDF:1.12MB/48 pages)
From CDC, MMWR, June 6, 2003, 52(RR10); 1-42. Attention: Non-MDH link
- Guidelines
for Preventing the Transmission of Mycobacterium Tuberculosis in Health-Care Facilities, 2005
From CDC, MMWR, December 30, 2005, 54(RR17);1-141. Attention: Non-MDH link
- Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis (PDF:543KB/62 pages) Attention: Non-MDH link
- Hepatotoxicity of Antituberculosis Therapy (2006)
An official statement from the American Thoracic Society. Attention: Non-MDH link
- Isolating Potentially Infectious Tuberculosis (TB) Patients - Recommendations from the Minnesota Department of Health
MDH recommendations for isolating potentially infectious tuberculosis (TB) patients in home and congregate settings.
- MDH Recommendations for the Use of the 12-week Isoniazid and Rifapentine Regimen for the Treatment of Latent Tuberculosis Infection (PDF: 82KB/3 pages)
MDH recommendations and special considerations for the use, administration, and patient monitoring for the 12-week LTBI treatment regimen.
- Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC (PDF:588KB/64 pages)
MMWR, July 7, 2006, 55(RR-9); 1-54. Attention: Non-MDH link
- Targeted TB Testing and Treatment of Latent Tuberculosis Infection (PDF:350KB/71 pages) National guidelines for health care providers. Attention: Non-MDH link
- Treatment
of Tuberculosis (PDF:1.46MB/88 pages)
Guidelines for treatment of TB disease. An official statement of the American Thoracic Society, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. MMWR, June 20, 2003, 52(RR11); 1-77. Attention: Non-MDH link
- Tuberculosis
and Air Travel Guidelines (PDF: 502KB/65 pages)
Recommendations from the World Health Organization regarding the risk of TB on international flights. Attention: Non-MDH link
- Updated Guidelines
for Using Interferon Gamma Release Assays to Detect Mycobacterium
Tuberculosis Infection - United States, 2010 (PDF:501KB/28 pages)
CDC guidelines. MMWR, June 25, 2010, 59(RR-5); 1-25. Attention: Non-MDH link
- Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis (PDF:1.15MB/24 pages)
Note: The guidelines start on page 7 of the document. MMWR January 16, 2009, 58(01); 7-10. Attention: Non-MDH link
